CD63 and colorectal carcinoma: The 22 confirmed compounds (Table 1) produced a robust and reproducible CRC score on CD63-GFP signal (Fig. 1B) and, thus, were next subjected to further validation to determining whether they affected exosome biogenesis or secretion.